SANTORO, MARIA

SANTORO, MARIA  

Dipartimento di Medicina Sperimentale  

Mostra records
Risultati 1 - 20 di 132 (tempo di esecuzione: 0.027 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-set-2011 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf Articolo su rivista
2-set-2011 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf Articolo su rivista
1-ago-2014 A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M Articolo su rivista
1-ago-2021 Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon Fokam, J; Takou, D; Njume, D; Pabo, W; Santoro, M; Njom Nlend, A; Beloumou, G; Sosso, S; Moudourou, S; Teto, G; Dambaya, B; Djupsa, S; Tetang Ndiang, S; Ateba, Fn; Billong, Sc; Kamta, C; Bala, L; Lambo, V; Tala, V; Chenwi Ambe, C; Mpouel, Ml; Cappelli, G; Cham, F; Ndip, R; Mbuagbaw, L; Koki Ndombo, P; Ceccherini Silberstein, F; Colizzi, V; Perno, C; Ndjolo, A Articolo su rivista
1-nov-2015 An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project Andreoni, M; Marcotullio, S; Puro, V; De Carli, G; Tambussi, G; Nozza, S; Gori, A; Rusconi, S; Santoro, M; Clementi, M; Perno, Cf; d'Arminio Monforte, A; Maggiolo, F; Castagna, A; De Luca, A; Galli, M; Giacomelli, A; Borderi, M; Guaraldi, G; Calcagno, A; Di Perri, G; Bonora, S; Mussini, C; Di Biagio, A; Puoti, M; Bruno, R; Zuccaro, V; Antinori, A; Cinque, P; Croce, D; Restelli, U; Rizzardini, G; Lazzarin, A Articolo su rivista
23-dic-2021 Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study Fokam, J; Mpouel Bala, Ml; Santoro, M; Takou, D; Tala, V; Beloumou, G; Ngoufack, Es; Chenwi, C; Pabo Willy Leroi, T; Njume, D; Teto, G; Dambaya, B; Djupsa, S; Sosso, S; Ateba, F; Kamta, C; Bala, L; Njom Nlend, A; Koki Ndombo, P; Colizzi, V; Perno, Cf; Ndjolo, A Articolo su rivista
13-apr-2021 Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings Semengue, Enj; Armenia, D; Inzaule, S; Santoro, M; Dambaya, B; Takou, D; Teto, G; Nka, Ad; Yagai, B; Fabeni, L; Chenwi, C; Angong Beloumou, G; Djupsa Ndjeyep, Sc; Colizzi, V; Perno, C; Ceccherini-Silberstein, F; Fokam, J Articolo su rivista
3-lug-2022 Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice Armenia, D; Forbici, F; Bertoli, A; Berno, G; Malagnino, V; Gagliardini, R; Borghi, V; Gennari, W; Cicalini, S; Buonomini, A; Teti, E; Lanini, S; Latini, A; Sarmati, L; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Ceccherini-Silberstein, F; Santoro, M Articolo su rivista
1-nov-2020 Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry Galli, L; Parisi, Mr; Poli, A; Menozzi, M; Fiscon, M; Garlassi, E; Francisci, D; Di Biagio, A; Sterrantino, G; Fornabaio, C; Degli Antoni, A; Angarano, G; Fusco, Fm; D'Arminio Monforte, A; Corbelli, Gm; Santoro, M; Zazzi, M; Castagna, A Articolo su rivista
10-mag-2019 Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy Fabeni, L; Alteri, C; Berno, G; Scutari, R; Orchi, N; De Carli, G; Bertoli, A; Carioti, L; Gori, C; Forbici, F; Salpini, R; Vergori, A; Gagliardini, R; Cicalini, S; Mondi, A; Pinnetti, C; Mazzuti, L; Turriziani, O; Colafigli, M; Borghi, V; Montella, F; Pennica, A; Lichtner, M; Girardi, E; Andreoni, M; Mussini, C; Antinori, A; Ceccherini-Silberstein, F; Perno, Cf; Santoro, Mm Articolo su rivista
1-ott-2007 Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf Articolo su rivista
1-gen-2012 Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon Ceccarelli, L; Salpini, R; Moudourou, S; Cento, V; Santoro, M; Fokam, J; Takou, D; Nanfack, A; Dori, L; Torimiro, J; Sarmati, L; Andreoni, M; Perno, Cf; Colizzi, V; Cappelli, G Articolo su rivista
1-set-2008 Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria Santoro, M; Ciccozzi, M; Alteri, C; Montieri, S; Alexiev, I; Dimova, I; CECCHERINI SILBERSTEIN, F; Beshkov, D; Rezza, G; Perno, Cf Articolo su rivista
1-gen-2013 Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study Giuliani, M; Santoro, M; Lo Presti, A; Cella, E; Scognamiglio, P; Lai, A; Latini, A; Fabeni, L; Gori, C; Pinnetti, C; Girardi, E; Perno, Cf; Zehender, G; Ciccozzi, M Articolo su rivista
1-apr-2016 Clinical relevance of genotypic resistance testing today Santoro, M; Perno, Cf Articolo su rivista
1-gen-2004 Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization Buschini, A; Martino, A; Gustavino, B; Monfrinotti, M; Poli, P; Rossi, C; Santoro, M; Dorr, A; Rizzoni, M Articolo su rivista
1-gen-2012 Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy Santoro, M; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf Articolo su rivista
12-lug-2017 Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains Fabeni, L; Berno, G; Fokam, J; Bertoli, A; Alteri, C; Gori, C; Forbici, F; Takou, D; Vergori, A; Zaccarelli, M; Maffongelli, G; Borghi, V; Latini, A; Pennica, A; Mastroianni, C; Montella, F; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Santoro, M Articolo su rivista
1-gen-2020 Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini-Silberstein, F Articolo su rivista
1-gen-2020 Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini Silberstein, F Articolo su rivista